University of Hull

University of Hull

Translational Oncology

Designed in close collaboration with an international team of clinicians and research specialists, this focused MSc provides an understanding of the causes and treatment of cancer from 'bench-to-bedside'. You study both theory and practice to gain the specialist knowledge and skills required to pursue an academic career in cancer research or move into the more applied fields of cancer treatment, hospital pathology or industry. The University has an international reputation for medical research and places a strong emphasis on cancer. This MSc is taught by a team of cancer research-focused staff from the School with internal and external expert guest lectures and seminars. We enjoy close collaborative links with NHS clinicians, clinical researchers and oncology staff who also deliver aspects of the programme. Students are immersed in an excellent research environment and infrastructure, specifically the recently completed £6 million, state-of-the-art, cancer research facility housed in the Allam Building. The University has invested in preclinical optical and radiological imaging and radiotherapy research. Students engage in research in cutting edge facilities employing these and other technologies used for the early diagnosis and treatment of cancer, both on campus and within the Hull Royal Infirmary and Castle Hill Hospital.

Entry requirements

A minimum 2.2 or equivalent in a biological science. Applicants with non-standard qualifications may apply, as appropriate experience will be taken into account during the selection process. International applicants - Competence in English is required for international students. For example: IELTS with 6.0 overall with 5.5 in each skill; previous study in English is accepted; candidates that do not meet the language requirements may take an English course at the University of Hull prior to entering the programme.

Course modules

This MSc is delivered by leading academic cancer scientists, research specialists, consultant clinical and medical oncologists, diagnosticians, radiologists, nurses and cancer surgeons, through a combination of lectures, expert seminars, state-of-the-art oncology-based practicals and projects supported by 'problem classes', workshops and tutorials.;

Laboratory-based work is an important part of the programme, which includes an extended 12-week oncology research project carried out in the laboratory of an internationally-recognised cancer researcher. This MSc programme is designed to provide a highly supportive environment, in which teamwork, project management and communication skills are as important as technical proficiency.;

Core modules:;
Cellular and Molecular Biology of Cancer;
Tumour Immunology and Microenvironment;
Treatment of Cancer;
Organ specific cancers: Bench-to Bedside;
Oncology Research Skills;
Research Project and Dissertation;

Optional modules:;
Clinical Statistics/Ethics in Oncology;
Cancer and Modifiable Risks;

Students are provided with in-depth specialist knowledge and insight into the fundamentals of Translational Oncology, alongside research-led teaching into the practical applications of cancer research. There is a strong emphasis on scientific method and associated skills.

Assessment methods



Qualification Study mode Start month Fee Course duration
MSc Full-time September 2016 GBP 5,815 per Year 1 (EU) 1 years
MSc Full-time September 2016 GBP 5,815 per Year 1 (England) 1 years
MSc Full-time September 2016 GBP 15,400 per Year 1 (International) 1 years
MSc Full-time September 2016 GBP 5,815 per Year 1 (Northern Ireland) 1 years
MSc Full-time September 2016 GBP 5,815 per Year 1 (Scotland) 1 years
MSc Full-time September 2016 GBP 5,815 per Year 1 (Wales) 1 years

Campus details

Campus name Town Postcode Region Main campus Campus Partner
Hull Campus Hull HU6 7RX Yorkshire and the Humber

Key information

Postgraduate Admissions
Telephone number: 
01482 466850